| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $13.9M | +18.8% |
| Cost of Revenue | $12.0M | +36.3% |
| Gross Profit | $1.24B | +15.4% |
| R&D Expense | $536K | +24.9% |
| SG&A Expense | $7.3M | +85.7% |
| Operating Income | -$9.8M | -106.0% |
| Interest Expense | $567K | — |
| Pre-tax Income | -$9.5M | -59.1% |
| Income Tax | $12K | +0.0% |
| Net Income | -$9.5M | -58.8% |
| EPS (Basic) | -$152.30 | — |
| EPS (Diluted) | -$152.30 | — |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.6M | — |
| Accounts Receivable | $2.1M | +86.5% |
| Current Assets | $13.2M | +805.7% |
| Total Assets | $22.7M | +1059.4% |
| Current Liabilities | $12.8M | +80.8% |
| Stockholders' Equity | $9.9M | +294.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$16.5M | -1428.5% |
| Capital Expenditures | $6K | — |
| Investing Cash Flow | -$1.8M | — |
| Financing Cash Flow | $25.9M | — |
| Free Cash Flow | -$16.5M | — |